Breaking Down Barriers to Care in Hepatitis C Virus Infection.
作者信息
Thursz Mark, Lacombe Karine
机构信息
Division of Digestive Disease, Imperial College, London, United Kingdom.
Department of Infectious Diseases and Tropical Medicine, Saint-Antoine Hospital, AP-HP Sorbonne Universités, UPMC University Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, France.
出版信息
J Infect Dis. 2016 Apr 1;213(7):1055-6. doi: 10.1093/infdis/jiv427. Epub 2015 Sep 2.
Abstract
摘要
相似文献
1
Breaking Down Barriers to Care in Hepatitis C Virus Infection.
J Infect Dis. 2016 Apr 1;213(7):1055-6. doi: 10.1093/infdis/jiv427. Epub 2015 Sep 2.
2
Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring.
J Infect Dis. 2016 Apr 1;213(7):1087-95. doi: 10.1093/infdis/jiv423. Epub 2015 Sep 2.
3
Comparison of Hepatitis C Virus RNA and antibody detection in dried blood spots and plasma specimens.
J Clin Virol. 2014 Apr;59(4):223-7. doi: 10.1016/j.jcv.2014.01.014. Epub 2014 Jan 27.
4
Disparate detection outcomes for anti-HCV IgG and HCV RNA in dried blood spots.
J Virol Methods. 2015 Feb;212:66-70. doi: 10.1016/j.jviromet.2014.10.018. Epub 2014 Nov 13.
5
Use of virologic assays in the diagnosis and management of hepatitis C virus infection.
Clin Liver Dis. 2005 Aug;9(3):371-82, v. doi: 10.1016/j.cld.2005.05.009.
6
Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
Vox Sang. 2004 May;86(4):266-7. doi: 10.1111/j.0042-9007.2004.00513.x.
7
Feasibility of freeze-dried sera for serological and molecular biological detection of hepatitis B and C viruses.
J Clin Microbiol. 2006 Dec;44(12):4593-5. doi: 10.1128/JCM.00621-06. Epub 2006 Oct 11.
8
Incidence of hepatitis C virus RNA in anti-HCV-negative plasma pools and blood products.
Vox Sang. 1996;70(4):232-4. doi: 10.1111/j.1423-0410.1996.tb01333.x.
9
Seronegative hepatitis C virus infection, not just RNA detection.
J Infect Dis. 2004 Aug 1;190(3):651-2. doi: 10.1086/421282.
10
Hepatitis C virus: biology and diagnosis.
Indian J Pathol Microbiol. 2000 Jul;43(3):377-82.
引用本文的文献
1
Unveiling the Silent Crisis Amidst Tackling Hepatitis B in African Prisons - A Public Health Emergency.
Health Sci Rep. 2025 Mar 10;8(3):e70543. doi: 10.1002/hsr2.70543. eCollection 2025 Mar.
2
Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019.
BMJ Open. 2023 Apr 18;13(4):e068237. doi: 10.1136/bmjopen-2022-068237.
3
Evaluation of the diagnostic accuracy of laboratory-based screening for hepatitis C in dried blood spot samples: A systematic review and meta-analysis.
Sci Rep. 2019 May 13;9(1):7316. doi: 10.1038/s41598-019-41139-8.
4
The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania.
J Viral Hepat. 2018 Dec;25(12):1438-1445. doi: 10.1111/jvh.12966. Epub 2018 Jul 30.
5
Evaluation of dried blood spot samples for screening of hepatitis C and human immunodeficiency virus in a real-world setting.
Sci Rep. 2018 Jan 30;8(1):1858. doi: 10.1038/s41598-018-20312-5.
6
Aiming at the Global Elimination of Viral Hepatitis: Challenges Along the Care Continuum.
Open Forum Infect Dis. 2017 Nov 17;5(1):ofx252. doi: 10.1093/ofid/ofx252. eCollection 2018 Jan.
7
Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania.
J Int AIDS Soc. 2017 Sep 19;20(1):21856. doi: 10.7448/IAS.20.1.21856.
8
HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.
J Int AIDS Soc. 2017 May 15;20(1):21446. doi: 10.7448/IAS.20.1.21446.
9
Hepatitis C treatment: where are we now?
Int J Gen Med. 2017 Feb 17;10:39-52. doi: 10.2147/IJGM.S127689. eCollection 2017.
本文引用的文献
1
Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring.
J Infect Dis. 2016 Apr 1;213(7):1087-95. doi: 10.1093/infdis/jiv423. Epub 2015 Sep 2.
2
Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy.
Clin Infect Dis. 2015 Jun 15;60(12):1743-51. doi: 10.1093/cid/civ170. Epub 2015 Mar 2.
3
Viral hepatitis: Scaling up HCV treatment in resource-limited countries.
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):193-4. doi: 10.1038/nrgastro.2015.31. Epub 2015 Feb 24.
4
Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing.
J Epidemiol Community Health. 2014 Dec;68(12):1182-8. doi: 10.1136/jech-2014-204451. Epub 2014 Aug 28.
5
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.
N Engl J Med. 2014 May 22;370(21):1983-92. doi: 10.1056/NEJMoa1402338. Epub 2014 May 4.
6
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.
N Engl J Med. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454. Epub 2014 Apr 11.
7
Viral hepatitis and the Global Burden of Disease: a need to regroup.
J Viral Hepat. 2013 Sep;20(9):600-1. doi: 10.1111/jvh.12123.
8
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
9
Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.
Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. Epub 2013 Feb 4.
10
Dried blood spot for hepatitis C virus serology and molecular testing.
Hepatology. 2010 Mar;51(3):752-8. doi: 10.1002/hep.23407.
Zotero 插件